Friday, 20 Apr 2018
Health

New policies to ease the economic burden of cancer patients in China

BEIJING, April 15 (Xinhua) – A series of new policies on cancer treatment drugs in China will give more hope to patients suffering from the malignant disease in the country.
According to a statement released after an executive meeting of the State Council (cabinet) recently, as of May 1, all tariffs on general medical drugs including cancer drugs, alkali-resistant cancer drugs and imported traditional Chinese medicine medicines will be abolished.
VAT will also be reduced in the production and import of drugs with large margins, which experts believe will be more effective in relieving the economic burden on patients.
Taking into consideration the measures and procedures in question, the new policies are expected to contribute to a reduction in drug prices by at least 20 percent, said Shi Lo Wen, director of the Beijing University International Medical Research Center.
“These measures will effectively and significantly enhance the availability and comprehensiveness of medicines, reduce financial burdens on patient families, and help prevent disease-related poverty,” he said.
Statistics show that many cancer patients in China are struggling to get cheap, good-quality drugs.
According to the National Cancer Institute, the market for cancer treatment and resistance in China is more than 120 billion yuan (about 19.1 billion US dollars). However, the prices of medicines are still very high for ordinary working families.
In this context, experts expect that in the long run, higher production capacity will be increased for institutions and medical institutes at the grassroots level, and that the share of medicines among different regions will be balanced; therefore, urgent medicines, including the most effective resistance and treatment of cancer, will be available and more effective for the public Wherever they are.
“Further measures will be implemented to ensure that patients in need of effective, quality and cheaper medicines will need them at the time they need them,” the National Health Committee said.

Post Comment